Page last updated: 2024-11-05

n-nitrososarcosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-nitrososarcosine : A nitrosamine that is sarcosine in which the hydrogen attached to the nitrogen has been replaced by a nitroso group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID25811
CHEMBL ID352109
CHEBI ID82363
SCHEMBL ID1288195
MeSH IDM0060719

Synonyms (38)

Synonym
ccris 479
sarcosine, n-nitroso-
nitroso sarkosin [german]
nsar
hsdb 5117
n-nitrosomethylglycine
n-methyl-n-(carboxymethyl)nitrosamine
glycine, n-methyl-n-nitroso-
brn 1756162
n-methyl-n-nitrosoglycine
n-nitrososarcosine
2-(methylnitrosoamino)acetic acid
chebi:82363 ,
CHEMBL352109
2-[methyl(nitroso)amino]acetic acid
AKOS006274415
C19286
13256-22-9
unii-irc08hi7yx
irc08hi7yx ,
nitroso sarkosin
FT-0672996
FT-0672995
n-nitrososarcosine [iarc]
acetic acid, 2-(methylnitrosoamino)-
n-nitrososarcosine [hsdb]
nitrososarcosine, n-
[methyl(nitroso)amino]acetic acid
SCHEMBL1288195
HJMPSKKJHVWPBK-UHFFFAOYSA-N
(1-methyl-2-oxohydrazino)acetic acid #
DTXSID9074309
J-006190
Q27155901
2-(methyl(nitroso)amino)acetic acid
EN300-4274907
Z1198151307
n-nitroso sarcosine

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" A dose-response relationship was established for the formation of NPRO in rats in vivo, after concurrent administration of various concentrations of the precursors, L-proline and sodium nitrite."( Monitoring endogenous nitrosamine formation in man.
Bartsch, H; Ohshima, H, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
non-proteinogenic amino acid derivativeAny derivative of a non-proteinogenic amino acid resulting from reaction at an amino group or carboxy group, or from the replacement of any hydrogen by a heteroatom.
nitrosamineN-Nitroso amines, compounds of the structure R2NNO. Compounds RNHNO are not ordinarily isolable, but they, too, are nitrosamines. The name is a contraction of N-nitrosoamine and, as such, does not require the N locant.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID226732The compound was modelled in silico for carcinogenic potency; + = Carcinogen1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer-assisted studies of structure-activity relationships of N-nitroso compounds using pattern recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (42.86)18.7374
1990's5 (23.81)18.2507
2000's6 (28.57)29.6817
2010's1 (4.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.63 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.22 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.35%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (4.35%)4.05%
Observational0 (0.00%)0.25%
Other21 (91.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]